Jérémy Béguin, et al.
Molecular Therapy Oncolytics, September 2020 – Read the article
Publication
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
Par Lucie Larguier|2020-11-25T15:54:42+01:00septembre 2nd, 2020|Publication, TG6002|Commentaires fermés sur Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
À propos de l'auteur : Lucie Larguier
Articles similaires
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity